Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 22, 2024Cancer Research

Abstract 3963: Indoleamine 2,3-dioxygenase 1 (IDO1) regulates immune evasion in lymphoma

View Full Paper
Ask AI
Bookmark
Share

Authors

JPJihyun ParkSYSeung-Joo YooQHQianni Hu

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Park et al. (2024) studied this question.

synapsesocial.com/papers/68e72e2fb6db6435876a7878https://doi.org/10.1158/1538-7445.am2024-3963
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Abstract 6537: Tumor IDO1 drives resistance to adoptive cell transfer by suppressing T cell recruitment and effector function2026
  2. 2Abstract B027: Tumor IDO1 drives resistance to adoptive cell transfer by suppressing T cell recruitment and effector function2026
  3. 3Abstract 729: IDO1 inhibition enables IFNγ-elicited responsiveness of pulmonary breast cancer metastases to hypoxia-directed tumoricidal agents2024
  4. 4Abstract 4737: Utilizing patient-derived organoid tumor models to combat chemo-immunotherapy resistance in NSCLC2026
  5. 5High indoleamine 2,3-dioxygenase transcript levels predict better outcome after front-line cancer immunotherapy2024 · 10 citations